Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
Health News Review analysis of Bloomberg's coverage of PrEP

This story takes as a given that the drug being discussed is 92% effective for preventing HIV infections. Exploring that statistic would have uncovered some fundamental concerns about the value of this treatment approach.

Published
24 February 2015
From
Health News Review
New clues about viral rebound in Mississippi child thought cured of HIV

Clinicians involved in the care of a child many once hoped was cured of HIV have published details about the case in the New England Journal of Medicine. The authors found that the virus that eventually returned after the girl had been off antiretroviral therapy for more than 2 years was identical to her mother's viral strain. The case shows that HIV establishes a viral reservoir very soon after infection. Starting antiretroviral treatment a day after birth was not enough to prevent viral rebound, though it did appear to allow prolonged remission.

Published
23 February 2015
From
HIVandHepatitis.com
HIV Positive Guys Need To Consider Going On Meds Earlier — ACON

MORE HIV-positive men need to think about starting treatment straight after diagnosis if ambitious targets to end HIV transmission by 2020 are to be met, the head of New South Wales based LGBTI health body ACON has said. The comments come as the organisation launches a major new sexual health campaign that also aims to clear up confusion surrounding one of the newest buzzwords in the HIV lexicon: "undetectable".

Published
23 February 2015
From
Star Observer
Isentress (raltegravir) label update

On February 18, 2015, FDA approved changes to the Isentress (raltegravir) label to include updated information regarding the coadministration of raltegravir and aluminum and/or magnesium containing antacid.

Published
19 February 2015
From
FDA
Biologist's Work on 'Viral Reservoirs' May Have Impact on AIDS/HIV

A drug used to treat patients with multiple sclerosis and Crohn’s disease has confirmed how “viral reservoirs” form in patients living with HIV and AIDS and also proven effective in animal trials at blocking the pathways to those reservoirs in the brain and gut, according to new research conducted by Professor of Biology Ken Williams and colleagues from other universities.

Published
19 February 2015
From
Boston College Chronicle
Experimental AIDS Drug Stirs Talk Of Vaccine 'Alternative'

For more than three decades, scientists have tried unsuccessfully to develop an effective vaccine for HIV, the virus that causes AIDS. But now researchers say they have created an experimental drug that may function as a sort of "alternative" vaccine for the virus. The experimental drug, a protein known as eCD4-IG, blocks infection by keeping the virus from binding to the immune cells that are the virus's target. In tests on monkeys, the drug "candidate" proved to be extremely effective at blocking infection--even with the most virulent strains of HIV and its simian counterpart, SIV.

Published
19 February 2015
From
Huffington Post
Researchers may have caught HIV becoming more virulent

A study from Cuba has generated wide media interest because researchers have identified a particular variety of the virus which is associated with rapid post-diagnosis falls in

Published
19 February 2015
By
Gus Cairns
The Search for a Permanent Alternative to HIV Drugs

Researchers Carefully Tailor a Study to Find Patients to Test Going Off Antiretroviral Medication

Published
16 February 2015
From
Wall Street Journal
Health News Review analysis of Reuters' coverage of new hepatitis C drugs

We wish that more stories would bring some skeptical thinking to their coverage of expensive new hepatitis C treatments. The emphasis on short-term effects obscures the lack of long-term data about benefits.

Published
13 February 2015
From
Health News Review
Next-Generation HIV and Hep C Treatment Plans Ahead at CROI

New research on the treatment and prevention of HIV/AIDS and hepatitis C will dominate the Conference on Retroviruses and Opportunistic Infections (CROI) 2015, which this year adds a special session on Ebola.

Published
13 February 2015
From
Medscape (free registration required)

Filter by country